QA: Myokardia Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001552451_2019_Myokardia_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001552451, Myokardia Inc

  xvar xval
0 AssetsCurrent 319,446,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,138,000
3 remainder_Assets 82,669,000
4 LiabilitiesCurrent 36,677,000
5 LiabilitiesNoncurrent 9,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 120,612,412
9 ResearchAndDevelopmentExpense 93,254,011
10 remainder_Expenses 0
11 remainder_Revenues 33,558,000
12 remainder_NetIncome 83,907
13 remainder_ComprehensiveNetIncome -199,634
  yvar yval
0 Assets 407,253,000
1 Liabilities 36,686,000
2 Expenses 213,866,423
3 Revenues 33,558,000
4 StockholdersEquity 370,567,000
5 NetIncome -180,224,516
6 ComprehensiveNetIncome -180,324,333
7 BaseVar 345,823,482
8 EconomicCapitalRatiobeforeLimitedLiability 2.83
9 EconomicCapitalRatio 3.57

Edgar->Model Mapping

Feature Distribution

Change over Time